1318 related articles for article (PubMed ID: 15117885)
21. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
22. The role of fat tissue in the cholesterol lowering and the pleiotropic effects of statins--statins activate the generation of metabolically more capable adipocytes.
Erol A
Med Hypotheses; 2005; 64(1):69-73. PubMed ID: 15533614
[TBL] [Abstract][Full Text] [Related]
23. Statins: multiple mechanisms of action in the ischemic brain.
Cimino M; Gelosa P; Gianella A; Nobili E; Tremoli E; Sironi L
Neuroscientist; 2007 Jun; 13(3):208-13. PubMed ID: 17519364
[TBL] [Abstract][Full Text] [Related]
24. Translating the effects of statins: from redox regulation to suppression of vascular wall inflammation.
Antonopoulos AS; Margaritis M; Shirodaria C; Antoniades C
Thromb Haemost; 2012 Nov; 108(5):840-8. PubMed ID: 22872079
[TBL] [Abstract][Full Text] [Related]
25. The effects of statins on endothelium, inflammation and cardioprotection.
Elrod JW; Lefer DJ
Drug News Perspect; 2005 May; 18(4):229-36. PubMed ID: 16034478
[TBL] [Abstract][Full Text] [Related]
26. Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease.
Settergren M; Böhm F; Rydén L; Pernow J
Eur Heart J; 2008 Jul; 29(14):1753-60. PubMed ID: 18441323
[TBL] [Abstract][Full Text] [Related]
27. Statins and cardioprotection--more than just lipid lowering?
Ludman A; Venugopal V; Yellon DM; Hausenloy DJ
Pharmacol Ther; 2009 Apr; 122(1):30-43. PubMed ID: 19318042
[TBL] [Abstract][Full Text] [Related]
28. The nonlipid effects of statins on endothelial function.
Beckman JA; Creager MA
Trends Cardiovasc Med; 2006 Jul; 16(5):156-62. PubMed ID: 16781949
[TBL] [Abstract][Full Text] [Related]
29. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity.
Staal A; Frith JC; French MH; Swartz J; Güngör T; Harrity TW; Tamasi J; Rogers MJ; Feyen JH
J Bone Miner Res; 2003 Jan; 18(1):88-96. PubMed ID: 12510809
[TBL] [Abstract][Full Text] [Related]
30. Pleiotropic effects of statins.
Liao JK; Laufs U
Annu Rev Pharmacol Toxicol; 2005; 45():89-118. PubMed ID: 15822172
[TBL] [Abstract][Full Text] [Related]
31. Statins and blood coagulation.
Undas A; Brummel-Ziedins KE; Mann KG
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):287-94. PubMed ID: 15569822
[TBL] [Abstract][Full Text] [Related]
32. Rho GTPases, statins, and nitric oxide.
Rikitake Y; Liao JK
Circ Res; 2005 Dec; 97(12):1232-5. PubMed ID: 16339495
[TBL] [Abstract][Full Text] [Related]
33. [Novel actions of HMG-CoA reductase inhibitors(statins)--vascular and cerebral protection through inhibition of small GTPase Rho].
Sawada N; Itoh H; Nakao K
Nihon Rinsho; 2001 Dec; 59(12):2470-5. PubMed ID: 11766357
[TBL] [Abstract][Full Text] [Related]
34. Pleiotropic vascular protective effects of statins in perioperative medicine.
Fang SY; Roan JN; Luo CY; Tsai YC; Lam CF
Acta Anaesthesiol Taiwan; 2013 Sep; 51(3):120-6. PubMed ID: 24148741
[TBL] [Abstract][Full Text] [Related]
35. Non-lipid-related effects of statins.
Bellosta S; Ferri N; Bernini F; Paoletti R; Corsini A
Ann Med; 2000 Apr; 32(3):164-76. PubMed ID: 10821323
[TBL] [Abstract][Full Text] [Related]
36. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
[TBL] [Abstract][Full Text] [Related]
37. HMG CoA reductase inhibitors and renoprotection: the weight of the evidence.
Romayne Kurukulasuriya L; Athappan G; Saab G; Whaley Connell A; Sowers JR
Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):49-59. PubMed ID: 19124395
[TBL] [Abstract][Full Text] [Related]
38. Beyond lipid-lowering: effects of statins on endothelial nitric oxide.
Laufs U
Eur J Clin Pharmacol; 2003 Mar; 58(11):719-31. PubMed ID: 12634978
[TBL] [Abstract][Full Text] [Related]
39. Statins and protein prenylation in cancer cell biology and therapy.
Garcia-Ruiz C; Morales A; Fernandez-Checa JC
Anticancer Agents Med Chem; 2012 May; 12(4):303-15. PubMed ID: 22413970
[TBL] [Abstract][Full Text] [Related]
40. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins.
Lahera V; Goicoechea M; de Vinuesa SG; Miana M; de las Heras N; Cachofeiro V; Luño J
Curr Med Chem; 2007; 14(2):243-8. PubMed ID: 17266583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
